Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections
Page 1 of 1
Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections
Jon Moulton Tue Aug 14, 2012 10:05 am
Lai BS, Witola WH, El Bissati KE, Zhou Y, Mui E, Fomovska A, McLeod R. Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections. PNAS. 2012;[Epub ahead of print] doi:10.1073/pnas.1208775109
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 62
Location : Philomath, Oregon, USA -
Similar topics» Silencing of GRA10 protein expression inhibits Toxoplasma gondii intracellular growth and development
» Spiroindolone that inhibits PfATPase4 is a potent, cidal inhibitor of Toxoplasma gondii tachyzoites in vitro and in vivo
» Treatment of highly pathogenic filovirus infections using advanced antisense technology
» The Potential of Exon Skipping for Treatment for Duchenne Muscular Dystrophy
» Targeting mRNA Splicing as a Potential Treatment for Duchenne Muscular Dystrophy
» Spiroindolone that inhibits PfATPase4 is a potent, cidal inhibitor of Toxoplasma gondii tachyzoites in vitro and in vivo
» Treatment of highly pathogenic filovirus infections using advanced antisense technology
» The Potential of Exon Skipping for Treatment for Duchenne Muscular Dystrophy
» Targeting mRNA Splicing as a Potential Treatment for Duchenne Muscular Dystrophy
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum